Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 382

1.

Percutaneous coronary intervention using a full metal jacket with drug-eluting stents: major adverse cardiac events at one year.

Calé R, Teles RC, Almeida M, Rosário Id, Sousa PJ, Brito J, Raposo L, Gonçalves Pde A, Gabriel HM, Mendes M.

Arq Bras Cardiol. 2013 Aug;101(2):117-26. doi: 10.5935/abc.20130139. Epub 2013 Jul 2. English, Portuguese.

2.

Extended follow-up following "full-metal jacket" percutaneous coronary interventions with drug-eluting stents.

Basavarajaiah S, Naganuma T, Latib A, Hasegawa T, Sharp A, Rezq A, Sticchi A, Figini F, Amato A, Colombo A.

Catheter Cardiovasc Interv. 2014 Dec 1;84(7):1042-50. doi: 10.1002/ccd.25455. Epub 2014 Mar 11.

PMID:
24550090
3.

Long-term clinical outcome of rotational atherectomy followed by drug-eluting stent implantation in complex calcified coronary lesions.

Abdel-Wahab M, Baev R, Dieker P, Kassner G, Khattab AA, Toelg R, Sulimov D, Geist V, Richardt G.

Catheter Cardiovasc Interv. 2013 Feb;81(2):285-91. doi: 10.1002/ccd.24367. Epub 2012 May 2.

PMID:
22431433
4.

Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.

Lee MS, Sillano D, Latib A, Chieffo A, Zoccai GB, Bhatia R, Sheiban I, Colombo A, Tobis J.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):15-21. doi: 10.1002/ccd.21712.

PMID:
19089930
5.

Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry.

Harjai KJ, Kondareddy S, Pinkosky B, Harjai N, Orshaw P, Boura J.

J Interv Cardiol. 2013 Apr;26(2):153-62. doi: 10.1111/j.1540-8183.2013.12016.x. Epub 2013 Jan 31.

PMID:
23363439
6.

The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.

Chen SL, Han YL, Zhang YJ, Ye F, Liu HW, Zhang JJ, Xu B, Jiang TM, Zhou YJ, Lv SZ.

JACC Cardiovasc Interv. 2013 Dec;6(12):1233-41. doi: 10.1016/j.jcin.2013.08.006. Epub 2013 Nov 13.

7.
8.

Long term follow-up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesions.

Ybarra LF, Ribeiro HB, Pozetti AH, Campos CA, Esper RB, Lemos PA, Lopes AC, Kalil-Filho R, Ellis SG, Ribeiro EE.

Catheter Cardiovasc Interv. 2013 Dec 1;82(7):E856-63. doi: 10.1002/ccd.24781. Epub 2013 Aug 1.

PMID:
23239630
9.

Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions.

Coroleu SF, De Vita M, Burzotta F, Trani C, Porto I, Niccoli G, Leone AM, Tommasino A, Talarico GP, Schiavoni G, Crea F.

EuroIntervention. 2012 Oct;8(6):701-7. doi: 10.4244/EIJV8I6A109.

10.

Drug-eluting stents in patients with chronic kidney disease: a prospective registry study.

Shenoy C, Boura J, Orshaw P, Harjai KJ.

PLoS One. 2010 Nov 29;5(11):e15070. doi: 10.1371/journal.pone.0015070.

11.

Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.

Harskamp RE, Beijk MA, Damman P, Kuijt WJ, Woudstra P, Grundeken MJ, Kloek JJ, Tijssen JG, de Mol BA, de Winter RJ.

J Cardiovasc Med (Hagerstown). 2013 Jun;14(6):438-45. doi: 10.2459/JCM.0b013e328356a4fc.

PMID:
22828774
12.

Major adverse cardiovascular events after drug-eluting stent implantation in patients with single chronic total occlusion: a single-center registry.

Gilis-Siek N, Fijalkowski M, Jaguszewski M, Targonski R, Strozyk A, Cackowska M, Masiewicz E, Skarzynski P, Burakowski S, Chmielecki M, Lewicki L, Dubaniewicz W, Gruchala M, Ciecwierz D, Rynkiewicz A.

J Invasive Cardiol. 2013 Nov;25(11):567-72.

13.

Impact of gender on clinical outcomes after mTOR-inhibitor drug-eluting stent implantation in patients with first manifestation of ischaemic heart disease.

Niccoli G, Sgueglia GA, Cosentino N, Piro M, Toma A, Cataneo L, Fracassi F, Porto I, Leone AM, Burzotta F, Trani C, Crea F.

Eur J Prev Cardiol. 2012 Oct;19(5):914-26. doi: 10.1177/1741826711420001. Epub 2011 Aug 12.

PMID:
21840968
14.

Long-term outcomes of intravascular ultrasound-guided implantation of bare metal stents versus drug-eluting stents in primary percutaneous coronary intervention.

Cho YK, Hur SH, Park NH, Choi SW, Sohn JH, Cho HO, Park HS, Yoon HJ, Kim H, Nam CW, Kim YN, Kim KB.

Korean J Intern Med. 2014 Jan;29(1):66-75. doi: 10.3904/kjim.2014.29.1.66. Epub 2014 Jan 2.

15.

Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study.

Jones DA, Rathod KS, Gallagher S, Weerackody R, Knight CJ, Rothman MT, Mathur A, Jain AK, Timmis AD, Wragg A.

Catheter Cardiovasc Interv. 2013 May;81(6):E237-44. doi: 10.1002/ccd.24513. Epub 2012 Nov 14.

PMID:
22707383
16.

Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.

Abe D, Sato A, Hoshi T, Maruta S, Misaki M, Kakefuda Y, Watabe H, Hiraya D, Sakai S, Kawabe M, Takeyasu N, Aonuma K.

J Cardiol. 2014 Nov;64(5):377-83. doi: 10.1016/j.jjcc.2014.02.020. Epub 2014 Mar 28.

17.

Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.

Almalla M, Pross V, Marx N, Hoffmann R.

Coron Artery Dis. 2012 Nov;23(7):492-6.

PMID:
22990414
18.

Long-term efficacy and safety of drug-eluting stent implantation for patients with multiple coronary chronic total occlusions.

Zhang J, Han YL, Li Y, Wang SL, Jing QM, Wang XZ, Ma YY, Luan B, Wang G, Wang B.

Chin Med J (Engl). 2010 Apr 5;123(7):789-93.

19.

Safety and effectiveness of drug eluting stent in patients with ST elevation myocardial infarction undergoing primary angioplasty.

Romano M, Buffoli F, Tomasi L, Corrado L, Ferrari MR, Zanini R.

Catheter Cardiovasc Interv. 2008 May 1;71(6):759-63. doi: 10.1002/ccd.21529.

PMID:
18412066
20.

Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.

Zhang Q, Wang XL, Liao ML, Hu J, Yang ZK, Ding FH, Zhang JS, Du R, Zhu TQ, Shen WF, Zhang RY.

Catheter Cardiovasc Interv. 2015 Mar;85 Suppl 1:762-9. doi: 10.1002/ccd.25864.

PMID:
25630513
Items per page

Supplemental Content

Write to the Help Desk